Boundless Bio Inc. (BOLD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Boundless Bio Inc.

    NASDAQ: BOLD · Real-Time Price · USD
    1.24
    0.01 (0.81%)
    At close: Oct 06, 2025, 10:11 AM

    Boundless Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 1.09M 957K 942K 682K
    Gross Profit
    		 -1.09M -957K -942K -682K
    Operating Income
    		 -73.27M -54.8M -46.47M -25.3M
    Interest Income
    		 7.89M 5.28M 668K 96K
    Pretax Income
    		 -65.36M -49.43M -45.9M -25.21M
    Net Income
    		 -65.36M -49.43M -45.9M -25.21M
    Selling & General & Admin
    		 18M 12.16M 9.31M 6.02M
    Research & Development
    		 55.27M 41.68M 37.16M 19.28M
    Other Expenses
    		 -1.09M n/a -100K -5K
    Operating Expenses
    		 72.18M 54.8M 46.47M 25.3M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 73.27M 54.8M 46.47M 25.3M
    Income Tax Expense
    		 n/a n/a n/a -96K
    Shares Outstanding (Basic)
    		 16.98M 22.24M 22.24M 22.24M
    Shares Outstanding (Diluted)
    		 16.98M 22.24M 22.24M 22.24M
    EPS (Basic)
    		 -3.85 -2.22 -2.06 -1.13
    EPS (Diluted)
    		 -3.85 -2.22 -2.06 -1.13
    EBITDA
    		 -64.28M -48.48M -45.53M -24.62M
    EBIT
    		 -65.36M -49.43M -45.9M -25.21M
    Depreciation & Amortization
    		 1.09M 957K 942K 682K

    Add to Watchlist